Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10003 | 1036 | 35.6 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EPIBATIDINE | Author keyword | 43 | 39% | 8% | 87 |
2 | EPIBATIDINE ANALOGUES | Author keyword | 15 | 88% | 1% | 7 |
3 | A 85380 | Author keyword | 11 | 56% | 1% | 14 |
4 | ABT 594 | Author keyword | 9 | 55% | 1% | 12 |
5 | HOMOEPIBATIDINE | Author keyword | 9 | 83% | 0% | 5 |
6 | EPIBOXIDINE | Author keyword | 8 | 100% | 0% | 5 |
7 | I 123 5 IA 85380 | Author keyword | 8 | 100% | 0% | 5 |
8 | NIFENE | Author keyword | 8 | 100% | 0% | 5 |
9 | IST NEUROSCI FARMACOL CELLULARE MOL | Address | 7 | 64% | 1% | 7 |
10 | 2 F 18F A 85380 | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPIBATIDINE | 43 | 39% | 8% | 87 | Search EPIBATIDINE | Search EPIBATIDINE |
2 | EPIBATIDINE ANALOGUES | 15 | 88% | 1% | 7 | Search EPIBATIDINE+ANALOGUES | Search EPIBATIDINE+ANALOGUES |
3 | A 85380 | 11 | 56% | 1% | 14 | Search A+85380 | Search A+85380 |
4 | ABT 594 | 9 | 55% | 1% | 12 | Search ABT+594 | Search ABT+594 |
5 | HOMOEPIBATIDINE | 9 | 83% | 0% | 5 | Search HOMOEPIBATIDINE | Search HOMOEPIBATIDINE |
6 | EPIBOXIDINE | 8 | 100% | 0% | 5 | Search EPIBOXIDINE | Search EPIBOXIDINE |
7 | I 123 5 IA 85380 | 8 | 100% | 0% | 5 | Search I+123+5+IA+85380 | Search I+123+5+IA+85380 |
8 | NIFENE | 8 | 100% | 0% | 5 | Search NIFENE | Search NIFENE |
9 | 2 F 18F A 85380 | 6 | 100% | 0% | 4 | Search 2+F+18F+A+85380 | Search 2+F+18F+A+85380 |
10 | 2 F 18FLUORO A 85380 | 6 | 100% | 0% | 4 | Search 2+F+18FLUORO+A+85380 | Search 2+F+18FLUORO+A+85380 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EPIBATIDINE | 245 | 63% | 24% | 244 |
2 | EPIBATIDINE ANALOGS | 67 | 85% | 3% | 35 |
3 | HERBERT SMITHII | 53 | 95% | 2% | 18 |
4 | R C 11NICOTINE | 23 | 86% | 1% | 12 |
5 | 2 4 METHANOPROLINE 2 CARBOXY 2 4 METHANOPYRROLIDINE | 23 | 76% | 2% | 16 |
6 | POISON FROG | 20 | 38% | 4% | 41 |
7 | FLUORINE 18 FPH | 18 | 83% | 1% | 10 |
8 | EPIBOXIDINE | 17 | 100% | 1% | 8 |
9 | ANTINOCICEPTIVE PROPERTIES | 16 | 39% | 3% | 33 |
10 | 5 IODO A 85380 | 15 | 82% | 1% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Development of radioligands with optimized imaging properties for quantification of nicotinic acetylcholine receptors by positron emission tomography | 2010 | 20 | 64 | 86% |
Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors | 2013 | 6 | 48 | 75% |
Nicotinic agonists, antagonists, and modulators from natural sources | 2005 | 107 | 212 | 45% |
Central nicotinic receptors: Structure, function, ligands, and therapeutic potential | 2007 | 108 | 237 | 25% |
Design of Ligands for the nicotinic acetylcholine receptors: The quest for selectivity | 2004 | 81 | 217 | 49% |
Agonists at the alpha 4 beta 2 nicotinic acetylcholine receptors: Structure-activity relationships and molecular modelling | 2001 | 81 | 69 | 61% |
Neural nAChRs PET imaging probes | 2014 | 2 | 83 | 51% |
Musings on alpha 4 beta 2 nicotinic acetylcholine (nACh) receptor pharmacophore models | 2004 | 23 | 26 | 88% |
Recent developments in the synthesis of nicotinic acetylcholine receptor ligands | 2004 | 34 | 60 | 68% |
Recent syntheses of epibatidine. A review | 2002 | 27 | 45 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IST NEUROSCI FARMACOL CELLULARE MOL | 7 | 64% | 0.7% | 7 |
2 | PAUL ERRER VILLIGEN | 4 | 75% | 0.3% | 3 |
3 | 47W | 3 | 57% | 0.4% | 4 |
4 | NEUROL UROL DIS D47W | 3 | 100% | 0.3% | 3 |
5 | NEUROL UROL DIS | 3 | 24% | 1.2% | 12 |
6 | R47W | 3 | 35% | 0.6% | 6 |
7 | MOL NEUROPHARMACOLGERIATR CLIN | 2 | 67% | 0.2% | 2 |
8 | 4N5 | 2 | 50% | 0.3% | 3 |
9 | LRL QC | 2 | 50% | 0.3% | 3 |
10 | MULTIMODAL IMAGE PROC | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184900 | CYCLOPROPYLIMINIUM REARRANGEMENT//CYCLOPROPYLBENZIMIDAZOLES//DIHYDROPYRROLOBENZIMIDAZOLES |
2 | 0.0000178268 | NICOTINE//ALPHA 7//NICOTINIC RECEPTOR |
3 | 0.0000076556 | FP TZTP//IQNP//DEXETIMIDE |
4 | 0.0000069406 | GUINEA PIG BLADDER//NK2 TACHYKININ RECEPTOR//ACETYCHOLINE RELEASE |
5 | 0.0000067221 | ACYLNITROSO//BICYCLIC HYDRAZINES//NITROSO DIENOPHILES |
6 | 0.0000060025 | POLYSACCHARIDE DERIVED PHASE//HPLC RESOLUTION//CYCLOPROPYLOGS |
7 | 0.0000056343 | NICOTINE ABSTINENCE//MOL NEUROPSYCHOPHARMACOL//ALLERGY AND HYPERSENSITIVITY |
8 | 0.0000048679 | 1 AZABICYCLO330OCTANE//SK 946//PERHYDROPYRROLIZINE |
9 | 0.0000044477 | NEOSTIGMINE//INTRATHECAL NEOSTIGMINE//HOSP CLINDISCIPLINE ANESTHESIOL |
10 | 0.0000043940 | DECAHYDROQUINOLINES//PUMILIOTOXINS//PUMILIOTOXIN |